$0.05
(Market cap
$102 Mln
Recently Viewed
Clear AllMarket cap
$102 Mln
Revenue (TTM)
$311 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.6 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-5
Debt to Equity
0.7
Book Value
$3.5
EPS
$-2.5
Face value
--
Shares outstanding
73,586,183
CFO
$-226.93 Mln
EBITDA
$-453.20 Mln
Net Profit
$-692.89 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -42.3 | 14.0 | -38.7 | -64.6 | -52.8 | -52.2 | -- |
|
BSE Sensex*
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
| -66.2 | -23.5 | -12.9 | -73.2 | -9.0 | 25.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Health Catalyst (HCAT)
|
1.4 | 101.6 | 311.1 | -178.0 | -11.6 | -58.3 | -- | 0.4 |
| 7.9 | 5,292.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 1.0 | |
| 299.5 | 8,082.3 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10.8 | 1.1 | |
| 36.6 | 5,563.8 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.2 | |
| 121.5 | 7,074.2 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.8 | |
| 84.3 | 5,490.1 | 1,541.6 | 233.6 | 21.6 | 21.4 | 24.7 | 5.0 | |
| 178.6 | 9,353.6 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.8 | 13.0 | |
| 329.9 | 13,067.9 | 1,403.7 | 177.7 | 14.7 | 13.8 | 73.7 | 9.1 | |
| 117.6 | 6,632.6 | 738.3 | 48.9 | 11.4 | 2.4 | 136.7 | 3.2 | |
| 31.6 | 13,623.0 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.3 | 2.6 |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that... provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah. Read more
CEO & Director
Mr. Daniel D. Burton
CEO & Director
Mr. Daniel D. Burton
Headquarters
South Jordan, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Health Catalyst Inc (HCAT) is $1.38 (NASDAQ) as of 24-Apr-2026 16:00 EDT. Health Catalyst Inc (HCAT) has given a return of -52.8% in the last 3 years.
Since, TTM earnings of Health Catalyst Inc (HCAT) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.94
|
0.68
|
|
2024
|
-6.10
|
1.16
|
|
2023
|
-4.39
|
1.41
|
|
2022
|
-4.18
|
1.35
|
|
2021
|
-12.15
|
3.57
|
The 52-week high and low of Health Catalyst Inc (HCAT) are Rs 5.06 and Rs 0.96 as of 27-Apr-2026.
Health Catalyst Inc (HCAT) has a market capitalisation of $ 102 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Health Catalyst Inc (HCAT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.